Residual risk for additional recessive diseases in consanguineous couples
- PMID: 34316023
- DOI: 10.1038/s41436-021-01289-5
Residual risk for additional recessive diseases in consanguineous couples
Abstract
Purpose: Consanguineous couples are typically counseled based on familial pathogenic variants identified in affected children. The residual risk for additional autosomal recessive (AR) variants, however, remains largely understudied.
Methods: First, we surveyed pedigrees of 1,859 consanguineous families for evidence of more than one AR disease. Second, we mined our database of 1,773 molecularly tested consanguineous families to identify those with more than one AR disease. Finally, we surveyed 88 women from consanguineous unions who have undergone targeted prenatal testing for a familial AR variant and followed the pregnancy outcome (n = 144).
Results: We found suggestive evidence of more than one AR disease in 1.94% of consanguineous pedigrees surveyed. Of 1,773 molecularly characterized consanguineous families, 2.93% had evidence of at least two AR diseases (3.54% for first cousin or closer and 2.72% for second cousin or more distant). Furthermore, we found that in 2.78% of pregnancies negative for the familial variant, the pregnancy outcome was a child with a different AR disease.
Conclusion: Our results show that when counseling consanguineous couples for a familial AR variant, ~3% residual risk for additional AR variants should be discussed. This suggests that a broader testing strategy in consanguineous couples should be considered.
© 2021. The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics.
References
-
- Bittles AH. A community genetics perspective on consanguineous marriage. Community Genet. 2008;11:324–330. - PubMed
-
- Clark DW, Okada Y, Moore K, Mason D, Pirastu N, Gandin I, et al. Associations of autozygosity with a broad range of human phenotypes. Nat Commun. 2019;10:1–17. - DOI
-
- Alkuraya FS. Curt Stern Award address: a more perfect clinical genome—how consanguineous populations contribute to the medical annotation of the human genome. Am J Hum Genet. 2021;108:395–399. - DOI
-
- Alkuraya FS. How the human genome transformed study of rare diseases. Nature. 2021;590:218–219.
-
- Alkuraya F. Impact of new genomic tools on the practice of Clin Genet in consanguineous populations: the Saudi experience. Clin Genet. 2013;84:203–208. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
